C57BL/6JGpt-Gbp2em1Cd2105/Gpt
Gbp2-KO|Strain NO.T028952
Knockout (KO)
- Product Type:
- Quantity: - +
- Sex:
- Age:
- Genotype:
BASIC INFORMATION
| Strain Name: | C57BL/6JGpt-Gbp2em1Cd2105/Gpt |
| Strain Number: | T028952 |
| Official Symbol: | Gbp2 |
| Strain Strategy: | T028952.Gbp2 Cas9-KO Strategy-EN.pdf |
| Official Full Name: | guanylate binding protein 2 |
| NCBI Number: | 14469 |
| MGI Number: | 102772 |
| Chromosome: | 3 |
| Deletion (size): | -2105bp |
| Research Areas: | Developmental Biology,immune system,nervous system,vision/eye,Cytoskeleton,Cell biology,Molecular biology,mortality/aging,Cytoplasmic vesicle,Golgi apparatus,cell nucleus,hydrolytic enzyme |
| Strain Background: | [N000013] C57BL/6JGpt |
| Modification Type: | Knockout (KO) |
| Genotyping Protocols: | T028952.Gbp2 Genotyping Protocol(KO).pdf |
| Inventory Status: | Cryopreserved |
| Sale Status: | IF (Available for Distribution) |
| Health Status: | Specific pathogen free (SPF) |
| Publications: | 1. Novel 1-hydroxy phenothiazinium-based derivative protects against bacterial sepsis by inhibiting AAK1-mediated LPS internalization and caspase-11 signaling. Cell Death Dis (2022) |